Roundtable Discussion on “Collaborative Opportunities for Investment and Innovation in the Biomanufacturing Sector”

Department of Biotechnology (DBT) recently hosted a Roundtable Discussion on “Collaborative Opportunities for Investment and Innovation in the Biomanufacturing Sector” at inStem, Bengaluru.

The event brought together key stakeholders in the Indian biotechnology diaspora to address concerns and explore suggestions for advancing biomanufacturing endeavors. Distinguished speakers included Dr. Rajesh S. Gokhale, Secretary of the DBT, and Dr. Jitendra Kumar, Managing Director of BIRAC. The Association of Biotechnology Led Enterprises (ABLE), a prominent not-for-profit pan-India forum representing the Indian Biotechnology Sector, extended invitations to industry members, fostering a collaborative platform for dialogue. Dr. Maneesha Inamdar, Director of inStem, delivered the closing vote of thanks, underscoring the spirit of collaboration and advancement.

A highlight of the event was the address by Dr. Sethuraman Panchanathan, Director of the United States-National Science Foundation (US-NSF), showcasing international participation and cross-border cooperation in the biotechnology domain.

This gathering held additional significance due to an earlier signing ceremony for the ‘Implementation Agreement’ between DBT and US-NSF, which took place in New Delhi. During this ceremony, Dr. Jitendra Singh projected India’s impressive trajectory towards a $150 billion Bio-Economy by 2025, surpassing the remarkable milestone of over $100 billion achieved in 2022. Dr. Singh, overseeing the signing event, underscored the nation’s remarkable growth in the biotechnology sector.
We are truly delighted to have been a part of this dialogue. The exchange of ideas and perspectives was insightful, touching upon scopes with immense potential for shaping the industry.

Thank you, ABLE, for the opportunity to engage in this meaningful conversation.

Share This Post